Safety of gadoxetate disodium: Results from the clinical phase II–III development program and postmarketing surveillance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety of gadoxetate disodium: Results from the clinical phase II–III development program and postmarketing surveillance

Published:2015-02-02 Issue:3 Volume:42 Page:634-643
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J. Magn. Reson. Imaging

Author:

Endrikat Jan S.¹²,Dohanish Susan³,Balzer Thomas⁴,Breuer Josy A.M.¹

Affiliation:

1. Bayer HealthCare Pharmaceuticals, Medical Care, Global Medical and Clinical Affairs, Radiology & InterventionalBerlin Germany

2. Department of GynecologyObstetrics and Reproductive MedicineUniversity Medical School of SaarlandHomburg/Saar Germany

3. Bayer HealthCare Pharmaceuticals, Global Pharmacovigilance and Risk ManagementWhippany New Jersey USA

4. Bayer HealthCare Pharmaceuticals, Medical Care, Medical and Clinical Affairs, Radiology & InterventionalWhippany New Jersey USA

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmri.24838

Reference27 articles.

1. Gadoxetate Disodium–Enhanced MRI of the Liver: Part 1, Protocol Optimization and Lesion Appearance in the Noncirrhotic Liver

2. Comparison of Magnetic Properties of MRI Contrast Media Solutions at Different Magnetic Field Strengths

3. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.

4. Phase I clinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics, and MR imaging.

5. Dynamic and delayed contrast enhancement in upper abdominal MRI studies: Comparison of gadoxetic acid and gadobutrol

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the Ability of Gadobenate Dimeglumine and Gadolinium Ethoxybenzyl Dimeglumine to Display the major Features for Noninvasively Diagnosing Hepatocellular Carcinoma According to the LI-RADS 2018v;Technology in Cancer Research & Treatment;2024-01

2. Initial clinical experience with using a 1.5 Tesla MR-Linac for stereotactic body radiotherapy for cancer of the upper abdomen;2023-05-23

3. Gadoxetate-Enhanced MRI as a Diagnostic Tool in the Management of Hepatocellular Carcinoma: Report from a 2020 Asia-Pacific Multidisciplinary Expert Meeting;Korean Journal of Radiology;2022

4. Severe Thrombocytopenia and Disseminated Intravascular Coagulation in a Cirrhosis Patient After Intravenous Injection of Gadoxetic Acid;Journal of Magnetic Resonance Imaging;2021-10-29

5. Stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of liver metastases in oligometastatic patients: initial clinical experience;Radiation Oncology Journal;2021-03-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3